A detailed discussion on gynecology as a specialty between Prassan Vij, MD, and host Nachiket Bhatia, MD. They explore the rewards and challenges of this field, the importance…
Jennifer Lincoln, MD, a board-certified OBGYN, demonstrates a pelvic exam on a simulation model, explaining its components and purpose. She covers the external and internal anatomy assessed during…
NEW YORK (Reuters Health) – Endometrial cancer is associated with an elevated risk of colorectal cancer, but not breast cancer, according to study results in the April issue…
NEW YORK (Reuters Health) – Assuming a woman does not prefer a uterus-conserving procedure, hysterectomy is more cost-effective than myomectomy or uterine artery embolization (UAE) for treating symptomatic…
NEW YORK (Reuters Health) – Specialists at McGill University in Montreal have developed a fertility preservation protocol of immature oocyte retrieval, in vitro maturation, vitrification of the mature…
NEW YORK (Reuters Health) – A cytomegalovirus (CMV) vaccine reduces incident cases of CMV infection in women and has the potential to decrease congenital CMV infection, according to…
NEW YORK (Reuters Health) – The results of the largest ovarian cancer screening trial to date suggest that a transvaginal ultrasound strategy or a multimodal approach that includes…
NEW YORK (Reuters Health) – Women with migraines during pregnancy are at increased risk for stroke, MI, and other vascular disorders, according to a report in the March…
NEW YORK (Reuters Health) – Contrary to findings from a Dutch study, the results of a Swedish study suggest that long-term dietary intake of acrylamide does not raise…
NEW YORK (Reuters Health) – Many 12-year-olds who were delivered preterm at very low birthweight have lower IQs and more developmental problems than similarly aged children born at…
NEW YORK (Reuters Health) – Breastfeeding, both exclusive and partial, appears to lower the risk of sudden infant death syndrome (SIDS), according to a report in the March…
NEW YORK (Reuters Health) – For first-line tocolytic therapy before 32 weeks’ gestation, prostaglandin inhibitors appear to be the most effective and tolerable agents for delaying delivery for…
